AGP Picks
View all

Maryland Business Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Maryland Business Weekly.

Press releases published on September 3, 2026

Truth in Accounting Joins FOX45, WJLA, and The Baltimore Sun to Show Marylanders the Full Cost of Government
The Learning Experience Opens New Preschool and Daycare Center in Gaithersburg
PAC Machinery to Showcase Packaging Equipment, Sustainable Materials, and Flexible Packaging Solutions at PACK EXPO International 2026
Bikini Baristas Hold Employer Accountable in Wage Theft Class Action—Recovering Millions in Compensation
Patton und alfanar kooperieren als Partner™ zur Beschleunigung der sicheren digitalen Transformation der saudischen Strominfrastruktur
Patton y alfanar Partner™ acelerarán la transformación digital segura de la infraestructura energética de Arabia Saudita
Patton et alfanar Partner™ pour accélérer la transformation numérique sécurisée des infrastructures d’électricité saoudiennes
פאטון ו- alfanar Partner™ משתפות פעולה להאצת ההמרה הדיגיטלית המאובטחת של תשתיות החשמל בערב הסעודית
パットンとアルファナル Partner™、サウジアラビアの電力インフラにおけるセキュアなデジタルトランスフォーメーションを加速
Patton dan alfanar Partner™ untuk Mempercepat Transformasi Digital yang Aman pada Infrastruktur Listrik Arab Saudi
Patton e alfanar Partner™ Aceleram Transformação Digital Segura da Infraestrutura Elétrica Saudita
Patton และ alfanar Partner™…
Patton·alfanar, 사우디 전력 인프라의 안전한 디지털 전환 가속화 위해 전략적 협력
Patton dan alfanar Partner™ untuk Mempercepatkan Transformasi Digital Selamat bagi Infrastruktur Kuasa Arab Saudi
Patton 与 alfanar Partner™ 加速沙特电力基础设施安全数字化转型
Patton 與 alfanar Partner™ 加快推動沙特電力基建的安全數碼轉型
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPRY
CloudOffix Launches AI-Powered Recruitment Agency Management Module
Nordique Critical Metals Provides Update on Kwyjibo Rare Earth Project
Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Maryland Business Weekly

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.